Teva Chosen As 'Bellwether' In US Price-Fixing Litigation

Case Involving Israeli Generics Giant Selected As Priority For Trial

Litigation involving Teva has been selected as a “bellwether” case, making it a priority for trial as part of the ongoing US investigation into generic price-fixing.

Gavel
The decision is the latest development in US price-fixing litigation • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin